发明名称 New 3-amino-1H-indazole derivatives useful as tau protein phosphorylation inhibitors e.g. for treating neurodegenerative diseases, stroke, obesity, diabetes, hypertension, atherosclerosis and cancer
摘要 3-Amino-1H-indazole derivatives (I) are new. 3-Amino-1H-indazole derivatives of formula (I) and their isomers, tautomers and salts are new. R3 = 1-6C alkyl, aryl, aryl(1-6C)alkyl, heteroaryl, heteroaryl(1-6C)alkyl, 1-10C cycloalkyl-fused aryl, 1-10C cycloalkyl-fused heteroaryl, heterocyclyl, heterocycloalkyl, cycloalkyl, adamantyl, polycycloalkyl, alkenyl, alkynyl, CONR1R2, CSNR1R2, COOR1, SO2R1, C(NH)R1 or C(NH)NHR1 (all optionally substituted by at least one halo, CN, NO2, NH2, OH, OR1, COOH, COOR1, OCOR1, NR1R2, NHCOR1, CONR1R2, SR1, SOR1, SO2R1, NHSO2R1, SO2NR1R2, CSNR1R2, NHCSR1, OSO2R1, SO3R1, aryl, heteroaryl, heterocyclyl, CHO, CF3, SCF3, OCF3 or 1-6C alkyl); R5, R6 = halo, CN, NO2, NH2, OH, OR1, COOH, COOR1, OCOR1, NR1R2, NHCOR1, CONR1R2, SR1, SOR1, SO2R1, NHSO2R1, SO2NR1R2, CSNR1R2, NHCSR1, OSO2R1, SO3R1, CF3, OCF3, 1-6C alkyl, aryl, aryl(1-6C)alkyl, heteroaryl, heteroaryl(1-6C)alkyl, heterocyclyl, cycloalkyl, alkenyl, alkynyl, adamantyl or polycycloalkyl (all optionally substituted by at least one halo, CN, NO2, NH2, OH, OR1, COOH, COOR1, OCOR1, NR1R2, NHCOR1, CONR1R2, SR1, SOR1, SO2R1, NHSO2R1, SO2NR1R2, CSNR1R2, NHCSR1, OSO2R1, SO3R1, aryl, heteroaryl, heterocyclyl, CHO, CF3, SCF3, OCF3 or 1-6C alkyl); R1, R2 = H, 106C alkyl, aryl, alkenyl, alkynyl or heteroaryl (all optionally substituted by at least one halo, 1-6C alkyl, 1-6C alkoxy, CN, NO2, NH2, OH, COOH, alkoxycarbonyl, CONH2, CHO, CF3 or OCF3, or R1 + R2 = 5- or 6-membered ring, provided that R5 and/or R6 is optionally substituted aryl when R3 is 6-membered N-heteroaryl, thiazolyl, imidazolyl or oxazolyl. Independent claims are also included for: (1) preparation of (I), and (2) 3-amino-5-phenyl-6-chloro-1-(2-trimethylsilyloxyethoxymethyl)-indazole, N-(5-phenyl-6-chloro-1-(2-trimethylsilyloxyethoxymethyl)-3-indazolyl)-butanamide, N-(5-bromo-6-chloro-1-(2-trimethylsilyloxyethoxymethyl)-3-indazolyl)-butanamide and N-(6-chloro-1-(2-trimethylsilyloxyethoxymethyl)-3-indazolyl)-butanamide as intermediates.
申请公布号 FR2844267(A1) 申请公布日期 2004.03.12
申请号 FR20020010962 申请日期 2002.09.05
申请人 AVENTIS PHARMA SA 发明人 LESUISSE DOMINIQUE;DUTRUC ROSSET GILLES;HALLEY FRANCK;BABIN DIDIER;ROONEY THOMAS
分类号 A61P3/00;A61P9/00;A61P25/28;A61P35/00;A61P37/00;C07D231/56;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D413/12;(IPC1-7):C07D231/56;C07D413/14;C07D411/12;A61K31/416 主分类号 A61P3/00
代理机构 代理人
主权项
地址